↓ Skip to main content

Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease

Overview of attention for article published in Frontiers in immunology, July 2022
Altmetric Badge

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease
Published in
Frontiers in immunology, July 2022
DOI 10.3389/fimmu.2022.920333
Pubmed ID
Authors

Antonius T. Otten, Arno R. Bourgonje, Petra P. Horinga, Hedwig H. van der Meulen, Eleonora A. M. Festen, Hendrik M. van Dullemen, Rinse K. Weersma, Coretta C. van Leer-Buter, Gerard Dijkstra, Marijn C. Visschedijk

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 17%
Student > Bachelor 2 11%
Unknown 13 72%
Readers by discipline Count As %
Medicine and Dentistry 2 11%
Immunology and Microbiology 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Unknown 14 78%